McGowan Group Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,553
Closed -$248K 134
2024
Q3
$248K Buy
8,553
+19
+0.2% +$554 0.03% 111
2024
Q2
$239K Buy
+8,534
New +$235K 0.03% 112
2023
Q3
Sell
-6,929
Closed -$254K 136
2023
Q2
$254K Sell
6,929
-320
-4% -$12.5K 0.04% 123
2023
Q1
$296K Buy
7,249
+53
+0.7% +$2.29K 0.05% 110
2022
Q4
$369K Buy
7,196
+618
+9% +$29.6K 0.06% 93
2022
Q3
$288K Buy
6,578
+37
+0.6% +$1.8K 0.05% 91
2022
Q2
$343K Buy
6,541
+60
+0.9% +$3.06K 0.06% 84
2022
Q1
$336K Buy
+6,481
New +$336K 0.05% 91
2020
Q3
Sell
-18,827
Closed -$584K 92
2020
Q2
$584K Buy
18,827
+3,874
+26% +$132K 0.11% 54
2020
Q1
$463K Buy
14,953
+9,526
+176% +$325K 0.1% 54
2019
Q4
$202K Buy
+5,427
New +$193K 0.03% 90
2019
Q3
Sell
-5,556
Closed -$228K 97
2019
Q2
$228K Sell
5,556
-47
-0.8% -$1.87K 0.04% 98
2019
Q1
$226K Sell
5,603
-8
-0.1% -$320 0.04% 98
2018
Q4
$232K Buy
5,611
+561
+11% +$23.3K 0.04% 86
2018
Q3
$211K Buy
+5,050
New +$194K 0.04% 103

Other funds holding PFE

McGowan Group Asset Management's PFE Position: Q4 2024 in Review

McGowan Group Asset Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 8,553 shares — an estimated $248K sold.

McGowan Group Asset Management first reported a position in PFE in Q3 2018 and held it in 15 quarters. The position peaked at $584K in Q2 2020. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • McGowan Group Asset Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • McGowan Group Asset Management sold 8,553 Pfizer shares in Q4 2024, an estimated $248K.
  • McGowan Group Asset Management first reported a position in Pfizer in Q3 2018 and held it in 15 quarters.
  • McGowan Group Asset Management's Pfizer position peaked at $584K in Q2 2020.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on McGowan Group Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.